Three days ago we launched the Startup Genome Compass, a benchmarking tool for startups and our new research on the primary cause of failure for startups: premature scaling.
There's been some confusion about exactly what we mean by premature scaling and we wanted to respond to the feedback we've received and elaborate on the findings from our research. To make it clearer, we need to go a little bit deeper into the theory and methodology.
Since February we've amassed a dataset of over 3200 high growth technology startups. Our latest research found that the primary cause of failure is premature scaling, an affliction that 70% of startups in our dataset possess.
The difference in performance between startups that scale prematurely and startups that scale properly is pretty striking. We found that:
- No startup that scaled prematurely passed the 100,000 user mark.
- 93% of startups that scale prematurely never break the $100k revenue per month threshold.
- Startups that scale properly grow about 20 times faster than startups that scale prematurely.